Search details
1.
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection.
PLoS Pathog
; 19(11): e1011772, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37943890
2.
Impact of SARS-CoV-2 exposure history on the T cell and IgG response.
Cell Rep Med
; 4(1): 100898, 2023 01 17.
Article
in English
| MEDLINE | ID: mdl-36584684
3.
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection.
medRxiv
; 2023 Mar 15.
Article
in English
| MEDLINE | ID: mdl-36993404
Results
1 -
3
de 3
1
Next >
>>